Doctor profile · Federal record
Dr. Melissa Manriques, BC, FNP
Primary Care Nurse Practitioner (CMS: Nurse Practitioner) · Fresno, CA
- NPI 1679564140
- Accepts Medicare
- MIPS 96.1 / 100 · 2023
- 23 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1095 E Warner Ave, # 101
Fresno, CA 937104043
(559) 435-3567 - Mailing address
-
132 Lind Ave
Clovis, CA 936120934
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- December 9, 2009
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 363LP2300X — NUCC code
- State license (1)
- California #14171
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1679564140. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,850
Distinct HCPCS
10
Medicare allowed
$97,757
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 675 | 112 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 455 | 303 | $79 | |
17110 |
Destruction of skin growth, 1-14 growths | 184 | 146 | $102 | |
17000 |
Destruction of precancer skin growth, 1 growth | 177 | 145 | $44 | |
11102 |
Biopsy of related skin growth, first growth | 150 | 129 | $76 | |
11103 |
Biopsy of related skin growth, each additional growth | 61 | 46 | $45 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 54 | 54 | $96 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 47 | 42 | $111 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 34 | 31 | $151 | |
17111 |
Destruction of skin growth, 15 or more growths | 13 | 12 | $119 |
In context: peer comparison
Among 4 peers in Fresno Primary Care Nurse Practitioner, average services per provider: 100. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$702
Transactions
23
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Incyte Corporation | 5 | $159.38 | |
| Pfizer INC. | 4 | $131.42 | |
| Leo Pharma INC. | 1 | $98.79 | |
| Janssen Biotech, INC. | 1 | $94.99 | |
| Abbvie INC. | 2 | $49.81 | |
| Biofrontera INC. | 4 | $45.43 | |
| Galderma Laboratories, L.P. | 2 | $37.35 | |
| Genzyme Corporation | 1 | $29.51 | |
| Lilly USA, LLC | 1 | $22.71 | |
| Revance Therapeutics, INC. | 1 | $19.00 | |
| Arcutis Biotherapeutics, INC. | 1 | $13.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
469
Patients
202
Total drug cost
$381,721
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 95 | 53 | $2,771 |
| Triamcinolone Acetonide | Generic | 86 | 53 | $874 |
| Clobetasol Propionate | Generic | 59 | 34 | $5,219 |
| Dupixent Pen (Dupilumab) | Brand | 47 | 0 | $182,317 |
| Doxycycline Hyclate | Generic | 41 | 15 | $1,093 |
| Metronidazole | Generic | 23 | 14 | $2,156 |
| Hydrocortisone | Generic | 21 | 18 | $157 |
| Mupirocin | Generic | 17 | 15 | $148 |
| Clindamycin Phosphate | Generic | 15 | 0 | $564 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 15 | 0 | $541 |
Frequently asked questions
What is Dr. Melissa Manriques's medical specialty?
Dr. Melissa Manriques practices Primary Care Nurse Practitioner in Fresno, CA.
Where does Dr. Melissa Manriques practice?
Dr. Melissa Manriques practices at 1095 E Warner Ave, Fresno, CA 937104043. Office phone: 5594353567.
What is Dr. Melissa Manriques's NPI?
Dr. Melissa Manriques's National Provider Identifier (NPI) is 1679564140, issued by NPPES.
Does Dr. Melissa Manriques accept Medicare assignment?
Yes. Dr. Melissa Manriques accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Melissa Manriques commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.